Total Payments
$19,784
2024 Payments
$7,001
Companies
7
Transactions
88
Medicare Patients
12
Medicare Billing
$62.32
Payment Breakdown by Category
Consulting$9,250 (46.8%)
Other$3,600 (18.2%)
Travel$3,002 (15.2%)
Research$2,183 (11.0%)
Food & Beverage$1,713 (8.7%)
Education$35.93 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,250 | 3 | 46.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,600 | 2 | 18.2% |
| Travel and Lodging | $3,002 | 12 | 15.2% |
| Unspecified | $2,183 | 18 | 11.0% |
| Food and Beverage | $1,713 | 52 | 8.7% |
| Education | $35.93 | 1 | 0.2% |
Payments by Type
General
$17,601
70 transactions
Research
$2,183
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $10,038 | 24 | $0 (2024) |
| Gilead Sciences, Inc. | $7,034 | 25 | $0 (2024) |
| ViiV Healthcare Company | $2,459 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $181.27 | 12 | $0 (2022) |
| Merck Sharp & Dohme LLC | $41.80 | 1 | $0 (2024) |
| Amgen Inc. | $17.45 | 1 | $0 (2024) |
| PFIZER INC. | $12.46 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,001 | 26 | ABBVIE INC. ($5,279) |
| 2023 | $5,443 | 12 | Gilead Sciences, Inc. ($5,424) |
| 2022 | $4,790 | 16 | ABBVIE INC. ($4,723) |
| 2021 | $74.51 | 5 | Gilead Sciences, Inc. ($46.19) |
| 2020 | $76.44 | 5 | Janssen Biotech, Inc. ($76.44) |
| 2019 | $1,380 | 12 | ViiV Healthcare Company ($1,315) |
| 2018 | $903.82 | 11 | ViiV Healthcare Company ($867.89) |
| 2017 | $115.23 | 1 | Gilead Sciences Inc ($115.23) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.90 | General |
| 04/07/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/22/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.38 | General |
| 03/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.82 | General |
| 11/04/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/28/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.19 | General |
| 10/14/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/30/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.18 | General |
| 07/28/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/05/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 01/27/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 01/22/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 01/06/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 12/03/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/07/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/25/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/23/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: GASTROINTESTINAL | ||||||
| 05/22/2019 | ViiV Healthcare Company | — | — | In-kind items and services | $464.63 | Research |
| Study: A QUALITATIVE HYBRID III IMPLEMENTATION STUDY TO IDENTIFY AND EVALUATE | ||||||
| 05/22/2019 | ViiV Healthcare Company | — | — | In-kind items and services | $293.47 | Research |
| Study: A QUALITATIVE HYBRID III IMPLEMENTATION STUDY TO IDENTIFY AND EVALUATE | ||||||
| 05/22/2019 | ViiV Healthcare Company | — | — | In-kind items and services | $188.34 | Research |
| Study: A QUALITATIVE HYBRID III IMPLEMENTATION STUDY TO IDENTIFY AND EVALUATE | ||||||
| 05/22/2019 | ViiV Healthcare Company | — | — | In-kind items and services | $102.00 | Research |
| Study: A QUALITATIVE HYBRID III IMPLEMENTATION STUDY TO IDENTIFY AND EVALUATE | ||||||
| 05/22/2019 | ViiV Healthcare Company | — | — | In-kind items and services | $92.45 | Research |
| Study: A QUALITATIVE HYBRID III IMPLEMENTATION STUDY TO IDENTIFY AND EVALUATE | ||||||
| 05/22/2019 | ViiV Healthcare Company | — | — | In-kind items and services | $72.69 | Research |
| Study: A QUALITATIVE HYBRID III IMPLEMENTATION STUDY TO IDENTIFY AND EVALUATE | ||||||
| 05/22/2019 | ViiV Healthcare Company | — | — | In-kind items and services | $53.09 | Research |
| Study: A QUALITATIVE HYBRID III IMPLEMENTATION STUDY TO IDENTIFY AND EVALUATE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A QUALITATIVE HYBRID III IMPLEMENTATION STUDY TO IDENTIFY AND EVALUATE | ViiV Healthcare Company | $1,315 | 8 |
| A PHASE III, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY | ViiV Healthcare Company | $867.89 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 12 | 16 | $382.08 | $62.32 |
Total Patients
12
Total Services
16
Medicare Billing
$62.32
Procedure Codes
1
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82947 | Blood glucose (sugar) level | Office | 2020 | 12 | 16 | $382.08 | $62.32 | 16.3% |
About Blair Thedinger
Blair Thedinger is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1750606042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Blair Thedinger has received a total of $19,784 in payments from pharmaceutical and medical device companies, with $7,001 received in 2024. These payments were reported across 88 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($9,250).
As a Medicare-enrolled provider, Thedinger has provided services to 12 Medicare beneficiaries, totaling 16 services with total Medicare billing of $62.32. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Kansas City, MO
- Active Since 03/30/2010
- Last Updated 09/10/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750606042
Products in Payments
- MAVYRET (Drug) $9,877
- Biktarvy (Drug) $6,645
- DOVATO (Drug) $140.31
- SYMTUZA (Drug) $128.70
- Symtuza (Drug) $52.57
- Mavyret (Drug) $35.93
- RUKOBIA (Drug) $18.91
- Otezla (Drug) $17.45
- QULIPTA (Drug) $12.85
- COLOGUARD (Device) $12.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Family Medicine $38,004
Eric Aspinwall, Md, MD
Family Medicine — Payments: $33,048
Family Medicine $33,048
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Family Medicine $30,998
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Family Medicine $19,673
Teresa Marshall, M.d, M.D
Family Medicine — Payments: $19,051
Family Medicine $19,051
Michael Simanovsky, M.d, M.D
Family Medicine — Payments: $16,366
Family Medicine $16,366